Burnham Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$3.07M Buy
20,200
+10,000
+98% +$1.55M 0.86% 33
2016
Q1
$1.52M Sell
10,200
-200
-2% -$29.7K 0.48% 59
2015
Q4
$1.69M Hold
10,400
0.46% 60
2015
Q3
$1.44M Hold
10,400
0.38% 70
2015
Q2
$1.6M Hold
10,400
0.37% 71
2015
Q1
$1.66M Hold
10,400
0.38% 69
2014
Q4
$1.66M Buy
10,400
+300
+3% +$46.7K 0.38% 72
2014
Q3
$1.42M Hold
10,100
0.31% 87
2014
Q2
$1.2M Hold
10,100
0.26% 98
2014
Q1
$1.25M Hold
10,100
0.3% 85
2013
Q4
$1.15M Hold
10,100
0.27% 98
2013
Q3
$1.13M Hold
10,100
0.28% 95
2013
Q2
$996K Buy
+10,100
New +$1.05M 0.25% 102

Other funds holding AMGN

Burnham Asset Management's AMGN Position: Q2 2016 in Review

Burnham Asset Management increased its Amgen (AMGN) stake by 98% in Q2 2016, buying an estimated $1.55M and bringing the position to 20,200 shares worth $3.07M. The position accounts for 0.86% of the portfolio, ranked #33.

Burnham Asset Management first reported a position in AMGN in Q2 2013 and has held it in 13 quarters since. 1,472 funds tracked by Wall St. Rank hold AMGN as of Q2 2016.

  • Burnham Asset Management held 20,200 shares of Amgen worth $3.07M as of Q2 2016.
  • Burnham Asset Management bought 10,000 Amgen shares in Q2 2016, an estimated $1.55M.
  • Amgen made up 0.86% of Burnham Asset Management's portfolio in Q2 2016, its #33 holding.
  • Burnham Asset Management first reported a position in Amgen in Q2 2013 and has held it in 13 quarters since.
  • 1,472 funds tracked by Wall St. Rank held Amgen as of Q2 2016.

Based on Burnham Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.